Lester, yes you do have a skill (that I don't possess) so thanks. I work in pharma and it's interesting that some countries adhere strictly to their own rules (e.g., Japan), while others (US) play a little looser with the regulations. Every week that passes pushes us closer to uplisting. I don't buy the argument from BC that the Nasdaq needs to see 2 quarters of enhanced accounting oversight before they decide. As long as adequate controls are in place, that's acceptable. I have to believe there are plenty of small and large companies on the exchange with similar or weaker accounting controls. Hopefully we can stop having this discussion and you can piece together some forward-thinking DD on our growth, rather than lamenting, with the rest of us, the reasons for our continued OTC status.
Cheers.
MT
News 
Market Data 
Discover 
